We have over 20 years combined experience in clinical practice (intensive care, cardiology, general medicine) and academia (Cambridge, Oxford, UCL, Imperial, LSE).
Directors

Myura Nagendran
I completed my medical degree at Cambridge and Oxford before moving to London in 2013 for postgraduate medical training across a range of acute specialties (MRCP, FRCA, FFICM). I am board certified in intensive care medicine and practise within the NHS having previously also worked in the private sector.
My research has been published in journals including the BMJ, Lancet and Nature Medicine and featured by Fortune and BBC World. I continue to peer-review research and protocols for journals and funders including UK Reasearch and Innovation (UKRI). I was awarded a PhD in 2025 from Imperial College London for my work on clinical AI and the evaluation of explainability in high fidelity simulation settings.
I have consulted for public and private sector clients on projects related to home care monitoring and predictive AI decision support tools. I am also a co-author of DECIDE-AI, a reporting guideline for the early-stage clinical evaluation of AI-driven decision support systems.

Yang Chen
I grew up in Dundee, Scotland and studied medicine at Cambridge and Oxford University. Since 2013, I have worked as a medical doctor in London. Alongside my clinical practice in cardiology, I completed an Executive MSc in Health Economics, Outcomes and Management in Clinical Sciences at LSE. Between 2020-2021, I was Chief Registrar at St Bartholomew’s hospital and additionally co-created a management consulting fellowship for clinicians hosted by Deloitte UK.
My recent work has focused on clinical trials integrated within the electronic health record. As principal investigator of the THIRST Alert RCT, I led a team of clinicians and data scientists at UCL and UCLH. I have additionally reviewed research for journals such as the BMJ and the European Heart Journal as well as funders including the Swiss National Science Foundation.
I also consult and draft regulatory documents (FDA, CE, UKCA) for AI software as a medical device (SaMD), and have provided consultation on quality management systems for core lab services in cardiovascular imaging.